The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
A Review of HPV-Related Head and Neck Cancer
Open accessAbstract
Head and neck squamous cell carcinomas (HNSCCs) arise in the mucosal lining of the upper aerodigestive tract. Tobacco and alcohol use have been reported to be associated with HNSCC. Infection with high-risk human papillomaviruses (HPVs) has recently been implicated in the pathogenesis of HNSCCs. It is now widely accepted that high-risk HPV is a cause of almost all cervical cancers as well as some forms of HNSCCs. HPV-related HNSCCs are increasing. HPV-related HNSCCs and HPV-unrelated HNSCCs differ with respect to the molecular mechanisms underlying their oncogenic processes. HPV-related HNSCCs are known to have a better prognosis response to treatment as compared with HPV-unrelated HNSCCs. Therefore, in recent years, it has been required to accurately discriminate between HPV-related and HPV-unrelated HNSCCs. To diagnose the HPV-related HNSCCs, various methods including P16 immunohistochemistry, FISH, and genetic analyses of the HPV gene from histopathological and liquid biopsy specimens have been employed. Based on the results of the differential diagnosis, various treatments employing EGFR TKI and low-dose radiation have been employed. Here, we review the involvement of the HPV virus in HNSCCs as well as the molecular mechanism of carcinogenesis, classification, prognosis, diagnostic procedures, and therapy of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
Ang, K. K., Harris, J., Wheeler, R., Weber, R., Rosenthal, D. I., Nguyen-Tân, P. F., Westra, W. H., Chung, C. H., Jordan, R. C., Lu, C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0912217 · Cited by 6,566
Epidemiologic classification of human papillomavirus types associated with cervical cancer
Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J. F., & Meijer, C. J. L. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021641 · Cited by 6,249
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
Bonner, J. A., Harari, P. M., Giralt, J., Azarnia, N., Shin, D. M., Cohen, R. B., Jones, C. U., Sur, R., Raben, D., Jassem, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053422 · Cited by 5,115
Cunningham, D., Humblet, Y., Siena, S., Khayat, D., Bleiberg, H., Santoro, A., Bets, D., Mueser, M., Harstrick, A., Verslype, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033025 · Cited by 5,035
Comprehensive genomic characterization of head and neck squamous cell carcinomas
The Cancer Genome Atlas Network (2015) · Nature · doi:10.1038/nature14129 · Cited by 3,877
Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers
Gillison, M. L. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.9.709 · Cited by 3,101
Fakhry, C., Westra, W. H., Li, S., Cmelak, A., Ridge, J. A., Pinto, H., Forastiere, A., & Gillison, M. L. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn011 · Cited by 2,779
Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review
Kreimer, A. R., Clifford, G. M., Boyle, P., & Franceschi, S. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0551 · Cited by 2,184
Dürst, M., Gissmann, L., Ikenberg, H., & zur Hausen, H. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.12.3812 · Cited by 2,025
HPV-associated head and neck cancer: a virus-related cancer epidemic
Marur, S., D'Souza, G., Westra, W. H., & Forastiere, A. A. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70017-6 · Cited by 1,816
Saltz, L. B., Meropol, N. J., Loehrer, P. J., Needle, M. N., Kopit, J., & Mayer, R. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.182 · Cited by 1,694
Chaturvedi, A. K., Engels, E. A., Anderson, W. F., & Gillison, M. L. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.1713 · Cited by 1,567
Gillison, M. L., D'Souza, G., Westra, W., Sugar, E., Xiao, W., Begum, S., & Viscidi, R. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn025 · Cited by 1,543
Chapter 2: The burden of HPV-related cancers
Parkin, D. M., & Bray, F. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.111 · Cited by 1,385
Worldwide Trends in Incidence Rates for Oral Cavity and Oropharyngeal Cancers
Chaturvedi, A. K., Anderson, W. F., Lortet-Tieulent, J., Curado, M. P., Ferlay, J., Franceschi, S., Rosenberg, P. S., Bray, F., & Gillison, M. L. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.50.3870 · Cited by 1,293
A review of clinical trials of human papillomavirus prophylactic vaccines
Schiller, J. T., Castellsagué, X., & Garland, S. M. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.108 · Cited by 747
Rischin, D., Young, R. J., Fisher, R., Fox, S. B., Le, Q.-T., Peters, L. J., Solomon, B., Choi, J., O'Sullivan, B., Kenny, L. M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.2904 · Cited by 737
Lehtinen, M., Paavonen, J., Wheeler, C. M., Jaisamrarn, U., Garland, S. M., Castellsagué, X., Skinner, S. R., Apter, D., Naud, P., Salmerón, J., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70286-8 · Cited by 704
High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma.
Reed, A. L., Califano, J. A., Cairns, P., Westra, W. H., Jones, R. M., Koch, W. M., Ahrendt, S. A., Eby, Y. J., Sewell, D. A., Nawroz, H., et al. (1996) · PubMed · Cited by 662
Oral Sexual Behaviors Associated with Prevalent Oral Human Papillomavirus Infection
D’Souza, G., Agrawal, Y., Halpern, J., Bodison, S., & Gillison, M. L. (2009) · The Journal of Infectious Diseases · doi:10.1086/597755 · Cited by 586
Muñoz, N., Kjaer, S. K., Sigurdsson, K., Iversen, O.-E., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Brown, D. R., Koutsky, L. A., Tay, E. H., et al. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp534 · Cited by 566
Romagosa, C., Simonetti, S., López-Vicente, L., Mazo, A., Lleonart, M. E., Castellvi, J., & Ramon y Cajal, S. (2011) · Oncogene · doi:10.1038/onc.2010.614 · Cited by 509
Human Papillomavirus in Head and Neck Cancer: Its Role in Pathogenesis and Clinical Implications
Chung, C. H., & Gillison, M. L. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0784 · Cited by 418
The Epidemiology and Risk Factors of Head and Neck Cancer: a Focus on Human Papillomavirus
Ragin, C. C. R., Modugno, F., & Gollin, S. M. (2007) · Journal of Dental Research · doi:10.1177/154405910708600202 · Cited by 416
Keck, M. K., Zuo, Z., Khattri, A., Stricker, T. P., Brown, C. D., Imanguli, M., Rieke, D., Endhardt, K., Fang, P., Brägelmann, J., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2481 · Cited by 370
Chen, A. M., Felix, C., Wang, P.-C., Hsu, S., Basehart, V., Garst, J., Beron, P., Wong, D., Rosove, M. H., Rao, S., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30246-2 · Cited by 326
Tissue Distribution of Human Papillomavirus 16 DNA Integration in Patients with Tonsillar Carcinoma
Begum, S., Cao, D., Gillison, M., Zahurak, M., & Westra, W. H. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0587 · Cited by 325
Rampias, T., Sasaki, C., Weinberger, P., & Psyrri, A. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp017 · Cited by 264
Lechner, M., Frampton, G. M., Fenton, T., Feber, A., Palmer, G., Jay, A., Pillay, N., Forster, M., Cronin, M. T., Lipson, D., et al. (2013) · Genome Medicine · doi:10.1186/gm453 · Cited by 217
Immortalization of normal human oral keratinocytes with type 16 human papillomavirus
Park, N.-H., Min, B.-M., Li, S.-L., Huang, M. Z., & Doniger, J. (1991) · Carcinogenesis · doi:10.1093/carcin/12.9.1627 · Cited by 212
Suzuki, S., & Hosono, A. (2018) · Papillomavirus Research · doi:10.1016/j.pvr.2018.02.002 · Cited by 207
Lassen, P., Eriksen, J. G., Krogdahl, A., Therkildsen, M. H., Ulhøi, B. P., Overgaard, M., Specht, L., Andersen, E., Johansen, J., Andersen, L. J., et al. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.02.010 · Cited by 200
El-Mofty, S. K., & Lu, D. W. (2003) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200311000-00010 · Cited by 198
Kreimer, A. R., González, P., Katki, H. A., Porras, C., Schiffman, M., Rodriguez, A. C., Solomon, D., Jiménez, S., Schiller, J. T., Lowy, D. R., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70213-3 · Cited by 194
The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy
Bristow, R. G., Benchimol, S., & Hill, R. P. (1996) · Radiotherapy and Oncology · doi:10.1016/0167-8140(96)01806-3 · Cited by 192
Molecular and Cytogenetic Subgroups of Oropharyngeal Squamous Cell Carcinoma
Perrone, F., Suardi, S., Pastore, E., Casieri, P., Orsenigo, M., Caramuta, S., Dagrada, G., Losa, M., Licitra, L., Bossi, P., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1759 · Cited by 168
Strati, K., Pitot, H. C., & Lambert, P. F. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606698103 · Cited by 152
Mirghani, H., Amen, F., Tao, Y., Deutsch, É., & Lévy, A. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.10.001 · Cited by 145
Human papillomavirus in a necessary cause of invasive cervical cancer worldwide
(1999) · Pure Amsterdam UMC · doi:10.1002/(sici)1096-9896(199909)189:1 · Cited by 140
Steenbergen, R. D. M., Hermsen, M. A. J. A., Walboomers, J. M. M., Joenje, H., Arwert, F., Meijer, C. J. L. M., & Snijders, P. J. F. (1995) · PubMed · Cited by 127
Holzinger, D., Wichmann, G., Baboçi, L., Michel, A., Höfler, D., Wiesenfarth, M., Schroeder, L., Boscolo‐Rizzo, P., Herold‐Mende, C. C., Dyckhoff, G., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30697 · Cited by 126
Dowthwaite, S. A., Franklin, J. H., Palma, D. A., Fung, K., Yoo, J. J., & Nichols, A. C. (2012) · ISRN Oncology · doi:10.5402/2012/945162 · Cited by 116
Immortalization of oral keratinocytes by functional inactivation of the p53 and pRb pathways
Smeets, S. J., van der Plas, M., Schaaij‐Visser, T. B. M., van Veen, E. A. M., van Meerloo, J., Braakhuis, B. J. M., Steenbergen, R. D. M., & Brakenhoff, R. H. (2010) · International Journal of Cancer · doi:10.1002/ijc.25474 · Cited by 111
Butz, K., Geisen, C., Ullmann, A., Spitkovsky, D., & Hoppe‐Seyler, F. (1996) · International Journal of Cancer · Cited by 108
de Vicente, J. C., Gutiérrez, L. M. J., Zapatero, A. H., Forcelledo, M. F. F., Hernández, G., & Arranz, J. S. L. (2003) · Head & Neck · doi:10.1002/hed.10339 · Cited by 102
Ferris, R. L., Martínez, I., Sirianni, N., Wang, J., López‐Albaitero, A., Gollin, S. M., Johnson, J. T., & Khan, S. A. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.11.023 · Cited by 99
Jabbar, S. F., Strati, K., Shin, M. K., Pitot, H. C., & Lambert, P. F. (2010) · Virology · doi:10.1016/j.virol.2010.08.003 · Cited by 82
Human Papillomaviruses As Therapeutic Targets in Human Cancer
Hellner, K., & Münger, K. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.2186 · Cited by 80
p16 and ARF: activation of teenage proteins in old age
Ande, S., & Rudolph, K. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci23437 · Cited by 73
Prospects for prevention of HPV-driven oropharynx cancer
Kreimer, A. R. (2013) · Oral Oncology · doi:10.1016/j.oraloncology.2013.06.007 · Cited by 73
Mirghani, H., Amen, F., Moreau, F., Guigay, J., Hartl, D. M., & Guily, J. L. S. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2013.12.018 · Cited by 70
Gao, G., Johnson, S. H., Kasperbauer, J. L., Eckloff, B. W., Tombers, N. M., Vasmatzis, G., & Smith, D. I. (2014) · Journal of Clinical Virology · doi:10.1016/j.jcv.2013.12.006 · Cited by 49
Sexton, C. J., Proby, C. M., Banks, L., Stables, J. N., Powell, K. L., Navsaria, H. A., & Leigh, I. M. (1993) · Journal of General Virology · doi:10.1099/0022-1317-74-4-755 · Cited by 30
Epidemiology, Pathogenesis, and Prevention of Head and Neck Cancer
Olshan, A. F. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1472-9 · Cited by 30
Allen, B. N., Schneider, A., Victoria, B., et al. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00217 · Cited by 18
Failure of anti-EGFR therapy in p16-positive head and neck cancer
Roesler, R., & Schwartsmann, G. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70400-5 · Cited by 3
Cited by
Cell cycle regulation: p53-p21-RB signaling
Engeland, K. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-00988-z · Cited by 1,274
Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer
Cillo, A. R., Kürten, C. H. L., Tabib, T., Qi, Z., Onkar, S., Wang, T., Liu, A., Duvvuri, U., Kim, S., Soose, R. J., et al. (2020) · Immunity · doi:10.1016/j.immuni.2019.11.014 · Cited by 668
The oralome and its dysbiosis: New insights into oral microbiome-host interactions
Radaic, A., & Kapila, Y. L. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.02.010 · Cited by 467
The current state of molecular testing in the treatment of patients with solid tumors, 2019
El‐Deiry, W. S., Goldberg, R. M., Lenz, H., Shields, A. F., Gibney, G. T., Tan, A. R., Brown, J., Eisenberg, B., Heath, E. I., Phuphanich, S., et al. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21560 · Cited by 264
Targeted therapy for head and neck cancer: signaling pathways and clinical studies
Li, Q., Tie, Y., Alu, A., Ma, X., & Shi, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01297-0 · Cited by 253
Metadata
- Authors
- Kobayashi, K., Hisamatsu, K., Suzui, N., Hara, A., Tomita, H., & Miyazaki, T.
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2018-08-27
- Volume
- 7
- Issue
- 9
- Pages
- 241
- ISSN
- 2077-0383 (ISSN-L)
- OpenAlex
- W2889482450
- Cited by
- 282
- References
- 56
- FWCI
- 26.24
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.